Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 19

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2011; 17(19): 2424-2430
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2424

Table 2 Median carcinoembryonic antigen in types of immunoscintigraphy

Type 0-no disease; 1-liver metastases; 2-recurrence; 3-liver metastases and recurrence; 4-peritoneal carcinosis. CEA: Carcinoembryonic antigen.

Citation: Artiko V, Marković AK, Šobić-Šaranović D, Petrović M, Antić A, Stojković M, Žuvela M, Šaranović D, Stojković M, Radovanović N, Galun D, Milovanović A, Milovanović J, Bobić-Radovanović A, Krivokapic Z, Obradović V. Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer. World J Gastroenterol 2011; 17(19): 2424-2430
URL: https://www.wjgnet.com/1007-9327/full/v17/i19/2424.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i19.2424

Artiko V, Marković AK, Šobić-Šaranović D, Petrović M, Antić A, Stojković M, Žuvela M, Šaranović D, Stojković M, Radovanović N, Galun D, Milovanović A, Milovanović J, Bobić-Radovanović A, Krivokapic Z, Obradović V. Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer. World J Gastroenterol 2011; 17(19): 2424-2430 [PMID: 21633643 DOI: 10.3748/wjg.v17.i19.2424]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.